Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

MIXED(25)
DRUG(6)
dexamethasone
6 trials
phase_1phase_1_2phase_2
mayo-clinic, national-cancer-institute-nci
Ixazomib Citrate
4 trials
phase_1phase_1_2phase_2
mayo-clinic
Laboratory Biomarker Analysis
4 trials
phase_1phase_1_2phase_2
mayo-clinic
cyclophosphamide
3 trials
phase_1_2phase_2
mayo-clinic, national-cancer-institute-nci
Questionnaire Administration
2 trials
phase_1_2phase_2
mayo-clinic
Pharmacological Study
2 trials
phase_1_2
mayo-clinic
bortezomib
2 trials
phase_2
mayo-clinic, national-cancer-institute-nci
Venetoclax
1 trial
phase_1
mayo-clinic

+7 more interventions

15 unique interventions2 categories

Analytics

Trial Phases

Phase 13
Phase 26

Trial Status

Completed6
Terminated1

Role Distribution

Principal Investigator4
Other Roles3
PI Rate57%

Activity Timeline

Clinical Trials (7)

NCT03399539Phase 1Completed
Venetoclax, Ixazomib Citrate, and Dexamethasone in Treating Patients with Relapsed Multiple Myeloma
Recurrent Plasma Cell MyelomaT(11;14)
PrincipalinvestigatorStart date: 2018-05-02
NCT03012880Phase 2Completed
Ixazomib Citrate, Lenalidomide, Dexamethasone, and Daratumumab in Treating Patients With Newly Diagnosed Multiple Myeloma
Plasma Cell Myeloma
PrincipalinvestigatorStart date: 2017-04-20
NCT02633059Phase 1/2Completed
Idasanutlin, Ixazomib Citrate, and Dexamethasone in Treating Patients With Relapsed Multiple Myeloma
Loss of Chromosome 17pRecurrent Plasma Cell Myeloma
PrincipalinvestigatorStart date: 2015-12-30
NCT01864018Phase 1/2Completed
Ixazomib With Cyclophosphamide and Dexamethasone in Patients With Previously Untreated Symptomatic Multiple Myeloma or Light Chain Amyloidosis
AmyloidosisPlasma Cell Myeloma
PrincipalinvestigatorStart date: 2013-08-20
NCT00998049Phase 2Completed
Plerixafor in Treating Patients With Multiple Myeloma Previously Treated With Lenalidomide and Planning to Undergo Autologous Stem Cell Transplant
Multiple MyelomaRefractory Multiple MyelomaStage I Multiple Myeloma+2 more
Studychair
NCT01072773Phase 2Completed
Bortezomib, Cyclophosphamide, and Dexamethasone in Treating Patients With Primary Systemic Light Chain Amyloidosis
Primary Systemic Amyloidosis
Studychair
NCT01078441Phase 2Terminated
Bortezomib, Liposomal Doxorubicin Hydrochloride, Dexamethasone, and Cyclophosphamide in Treating Patients With Multiple Myeloma That Relapsed After Autologous Stem Cell Transplant
Refractory Multiple Myeloma
Studychair

Research Network

Collaboration Network

4 collaborators·3 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Joseph R. Mikhael, M.D.

Mayo Clinic

Similar
3 trials

Shared therapeutic areas:

Multiple MyelomaRefractory Multiple MyelomaStage I Multiple Myeloma+2 more

Worked with same sponsors:

Mayo ClinicNational Cancer Institute (NCI)
Collaborated on 1 trial
Similarity Score54%

Yifan Zhai, MD, PhD

Ascentage Pharma Group Inc.

Related
14 trials

Shared therapeutic areas:

AmyloidosisMultiple Myeloma
Similarity Score6%

David Avigan, MD

Beth Israel Deaconess Medical Center

Related
17 trials

Shared therapeutic areas:

Multiple MyelomaRefractory Multiple Myeloma

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score6%

PEGOURIE, MD

University Hospital, Grenoble

Related
1 trials

Shared therapeutic areas:

Multiple Myeloma
Similarity Score3%

Michel ATTAL, MD, PhD

University Hospital, Toulouse

Related
1 trials

Shared therapeutic areas:

Multiple Myeloma
Similarity Score3%

AUGEL MEUNIER, MD

CHU ST PRIEST EN JAREZ

Related
1 trials

Shared therapeutic areas:

Multiple Myeloma
Similarity Score3%

MOREL, MD

Hôpital la Pitié Salpêtrière Paris

Related
1 trials

Shared therapeutic areas:

Multiple Myeloma
Similarity Score3%

BENBRAHIM, MD

CH ORLEANS

Related
1 trials

Shared therapeutic areas:

Multiple Myeloma
Similarity Score3%

Areej El-Jawahri, MD

Massachusetts General Hospital

Related
21 trials

Shared therapeutic areas:

Multiple Myeloma

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score3%

Gustavo Leone

Medical University of South Carolina, Hollings Cancer Center

Related
12 trials

Shared therapeutic areas:

Multiple Myeloma
Similarity Score3%

Publications (0)

No publications found for this investigator.

Clinical Trials (7)

Showing 7 of 7 trials

NCT03399539Phase 1PrincipalInvestigator

Venetoclax, Ixazomib Citrate, and Dexamethasone in Treating Patients with Relapsed Multiple Myeloma

Recurrent Plasma Cell MyelomaT(11;14)
Completed
NCT03012880Phase 2PrincipalInvestigator

Ixazomib Citrate, Lenalidomide, Dexamethasone, and Daratumumab in Treating Patients With Newly Diagnosed Multiple Myeloma

Plasma Cell Myeloma
Completed
NCT02633059Phase 1/2PrincipalInvestigator

Idasanutlin, Ixazomib Citrate, and Dexamethasone in Treating Patients With Relapsed Multiple Myeloma

Loss of Chromosome 17pRecurrent Plasma Cell Myeloma
Completed
NCT01864018Phase 1/2PrincipalInvestigator

Ixazomib With Cyclophosphamide and Dexamethasone in Patients With Previously Untreated Symptomatic Multiple Myeloma or Light Chain Amyloidosis

AmyloidosisPlasma Cell Myeloma
Completed
NCT00998049Phase 2StudyChair

Plerixafor in Treating Patients With Multiple Myeloma Previously Treated With Lenalidomide and Planning to Undergo Autologous Stem Cell Transplant

Multiple MyelomaRefractory Multiple MyelomaStage I Multiple Myeloma+2 more
Completed
NCT01072773Phase 2StudyChair

Bortezomib, Cyclophosphamide, and Dexamethasone in Treating Patients With Primary Systemic Light Chain Amyloidosis

Primary Systemic Amyloidosis
Completed
NCT01078441Phase 2StudyChair

Bortezomib, Liposomal Doxorubicin Hydrochloride, Dexamethasone, and Cyclophosphamide in Treating Patients With Multiple Myeloma That Relapsed After Autologous Stem Cell Transplant

Refractory Multiple Myeloma
Terminated

All 7 trials loaded